etoposide has been researched along with Atrophy in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Bader, MM; Khan, KM; Kilarkaje, N; Mousa, AM | 1 |
Jereb, B; Macedoni-Luksic, M; Todorovski, L | 1 |
Carthew, P; Cohen, GM; Dinsdale, D; Snowden, RT; Sun, XM | 1 |
Kagawa, M; Kasai, Y; Kawaguchi, M; Nagaoka, Y; Wachi, M | 1 |
Hotta, T; Kiya, K; Kurisu, K; Mikami, T; Nakahara, T; Ogasawara, H; Sugiyama, K; Uozumi, T | 1 |
5 other study(ies) available for etoposide and Atrophy
Article | Year |
---|---|
Antioxidants enhance the recovery of three cycles of bleomycin, etoposide, and cisplatin-induced testicular dysfunction, pituitary-testicular axis, and fertility in rats.
Topics: alpha-Tocopherol; Animals; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Ascorbic Acid; Atrophy; Bleomycin; Blotting, Western; Cisplatin; Cytoprotection; Disease Models, Animal; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Fertility; Hormones; Immunohistochemistry; Male; Pituitary Gland; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Recovery of Function; Selenium; Sperm Count; Sperm Motility; Spermatogenesis; Testicular Diseases; Testis; Time Factors; Transferrin; Zinc | 2013 |
Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Brain Damage, Chronic; Brain Neoplasms; Calcinosis; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disabled Children; Epilepsy; Etoposide; Female; Humans; Hydrocephalus; Infant; Intellectual Disability; Learning Disabilities; Lomustine; Magnetic Resonance Imaging; Male; Methotrexate; Movement Disorders; Neoplasm Recurrence, Local; Prevalence; Procarbazine; Radiation Injuries; Slovenia; Survivors; Tomography, X-Ray Computed; Unemployment; Vincristine; Vision Disorders | 2003 |
The involvement of apoptosis in etoposide-induced thymic atrophy.
Topics: Animals; Apoptosis; Atrophy; Body Weight; Corticosterone; DNA; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Etoposide; Flow Cytometry; Male; Organ Size; Radioimmunoassay; Rats; Rats, Inbred F344; Thymus Gland; Time Factors | 1994 |
Collaborative work to evaluate toxicity on male reproductive organs by repeated dose studies in rats 14). Comparison of the effects of 2- and 4-weeks intravenous administration of etoposide.
Topics: Animals; Antineoplastic Agents, Phytogenic; Atrophy; Body Weight; Bone Marrow Cells; Dose-Response Relationship, Drug; Etoposide; Hematopoiesis, Extramedullary; Injections, Intravenous; Male; Organ Size; Rats; Rats, Sprague-Dawley; Spleen; Testis; Thymus Gland; Time Factors; Toxicity Tests | 2000 |
Effect of intracarotid infusion of etoposide with angiotensin II-induced hypertension on the blood-brain barrier and the brain tissue.
Topics: Angiotensin II; Animals; Atrophy; Blood-Brain Barrier; Brain; Brain Edema; Carotid Arteries; Demyelinating Diseases; Etoposide; Evans Blue; Hypertension; Infusions, Intra-Arterial; Male; Necrosis; Rats; Rats, Inbred F344 | 1992 |